Why Do People Take GLP-1? Exploring the Benefits and Uses of GLP-1 Agonists

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 agonists are medications originally developed to help manage type 2 diabetes, but research shows they can reduce body weight by 15-22% when combined with lifestyle changes. Today, millions of people use GLP-1 therapy for weight loss and improved metabolic function, even without a diabetes diagnosis. PlexusDx delivers compounded GLP-1 treatments to all 50 states, with options ranging from semaglutide injections to oral formulations and genetic testing for precision dosing.

How GLP-1 Agonists Work in Your Body

GLP-1 stands for glucagon-like peptide-1, a natural hormone your intestines release after eating. This hormone signals your brain to feel full, slows stomach emptying, and helps regulate blood sugar levels. When you take a GLP-1 agonist medication, it mimics this hormone's effects, triggering the same satiety and metabolic responses your body naturally produces.

The mechanism targets multiple pathways at once: appetite suppression in the brain, delayed gastric emptying so food stays in your stomach longer, improved insulin secretion, and enhanced glucose handling by your cells. This multi-system approach explains why GLP-1 therapy produces weight loss beyond simple calorie restriction. Studies show patients using GLP-1 agonists lose weight even when food intake remains constant, suggesting the medication changes how your body processes and stores energy.

Weight Loss Benefits of GLP-1 Therapy

Clinical trials demonstrate that GLP-1 agonists produce substantial weight reduction when used as prescribed. Semaglutide, one of the most studied options, showed average weight loss of 15-22% of baseline body weight over 68 weeks in landmark research. Tirzepatide, a dual GLP-1 and GIP receptor agonist, produced even greater reductions in some patient populations, with some individuals losing 25% or more of their starting weight.

Beyond the number on the scale, weight loss from GLP-1 therapy improves cardiovascular risk factors including blood pressure, cholesterol levels, and inflammation markers. Patients often report improved joint function, better sleep quality, and reduced stress on the heart and metabolic organs. PlexusDx helps you track these outcomes through personalized treatment protocols designed around your baseline health data and genetic predispositions.

GLP-1 for Blood Sugar Control and Metabolic Health

Even patients without diabetes benefit from GLP-1 agonists because they improve how your body handles glucose. These medications increase insulin secretion when blood sugar rises, decrease glucagon (which raises blood sugar), and enhance the ability of your muscles and liver to take up glucose from the bloodstream. The result is more stable blood sugar levels throughout the day, fewer energy crashes, and reduced cravings for sugary foods.

Improved glucose metabolism provides benefits beyond diabetes management: better cognitive function from stable energy, reduced inflammation linked to chronic disease, and protection against metabolic dysfunction. People using GLP-1 therapy often experience fewer afternoon energy slumps and better sustained focus during work or exercise. This metabolic improvement can persist even after weight loss is achieved, supporting long-term health maintenance.

Why Choose Compounded GLP-1 from PlexusDx

PlexusDx sources all GLP-1 medications from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity and potency without brand markups. PlexusDx offers semaglutide injections starting at $149 per month with a simple pricing model: your dose may need to go up, but your price won't. This flat-rate structure means you can adjust your treatment to your body's response without worrying about escalating costs.

PlexusDx serves all 50 states without requiring insurance, membership fees, or insurance pre-approvals. Treatment plans are HSA and FSA eligible, making them accessible to a broader range of patients. After your first month, the optional Precision Peptide Genetic Test ($99 add-on) maps your genetic variants across 14 metabolic pathways and 49 peptides, helping your PlexusDx clinician optimize your medication choice and dosing strategy based on your unique biology rather than trial-and-error adjustment.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Who should consider taking GLP-1 agonists?

GLP-1 agonists are appropriate for adults with a BMI over 27 who have weight-related health conditions, or BMI over 30 regardless of conditions. However, candidacy extends beyond these numbers—patients with metabolic dysfunction, prediabetes, or strong family histories of diabetes or weight issues may also benefit. PlexusDx clinicians evaluate your full health picture, including genetics and metabolic markers, before recommending a specific GLP-1 therapy.

How much weight can I expect to lose with GLP-1 therapy?

Average weight loss ranges from 10-25% of baseline body weight depending on the medication, dose, duration of treatment, and your adherence to lifestyle modifications. Semaglutide injection typically produces 15-22% weight loss, while tirzepatide often delivers greater reductions of 20-25% in clinical trials. Individual results vary significantly based on genetics, baseline metabolism, diet quality, and exercise consistency—this is why PlexusDx offers genetic testing to predict your medication response.

What medications does PlexusDx offer and what do they cost?

PlexusDx provides compounded semaglutide injection (starts at $149/month), oral semaglutide ($249/month), compounded tirzepatide injection ($249/month), oral tirzepatide ($279/month), microdose GLP-1 protocol ($129/month flat), and dual-compound GLP-Squared formulations. All are from licensed 503A pharmacies, HSA/FSA eligible, and available nationwide without insurance. Your dose may adjust upward over time, but your monthly price remains flat.

Are there common side effects with GLP-1 agonists?

Most side effects occur during dose escalation and diminish as your body adapts: nausea, vomiting, constipation, and reduced appetite are the most frequently reported. These effects typically last days to weeks rather than months. Serious adverse events are rare but can include pancreatitis or gallbladder issues; patients with personal or family history of medullary thyroid carcinoma should not use GLP-1 agonists. PlexusDx clinicians monitor your tolerability and adjust dosing protocols if side effects become bothersome.

How does PlexusDx's genetic test help personalize my GLP-1 therapy?

PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes plus 150+ other metabolic insights across 49 peptides. These variants predict how your body responds to different GLP-1 medications and optimal dosing ranges. For example, certain GLP1R variants correlate with stronger appetite suppression from semaglutide, while GIPR variants may indicate superior response to tirzepatide's dual-action mechanism. This genetic roadmap eliminates guesswork and accelerates your path to the right medication and dose.

Related Reading

• Glp Receptor 1 Agonists
• Glp 1 Receptor Agonists For Weight Loss
• Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications
• Maximus Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.